A few analysts believe revenues have bottomed out for drug maker Jubilant Pharmova, others do not hold high hopes in the short term

In the Nifty50 index, 47 stocks closed in the green, while 3 stocks ended in the red.

Due to the spurt in demand, states like Madhya Pradesh ,Gujarat , Maharashtra are reporting shortage of the remdesivir injection, a key dru...

Shares of Jubilant Lifesciences soared over 12 per cent to record its biggest intraday gain.

The issue is said to have attracted high quality investors including private banks and asset management companies such as Fidelity and HSBC...

Shares of Jubilant Lifesciences surged 6 per cent in trade on Monday after the firm received final approval for its generic drug from USFDA.

Indian drug makers may be receiving an increasing number of approvals from the USFDA for drug launches in the United States.

'Jubilant Lifesciences is a 'BUY' call with a target of Rs 330 and a stop loss of Rs 295'

The US FDA cites the reason of recall as "cGMP deviations, oral products were not manufactured in accordance with good manufacturing practi...

Anand Mahindra said “We will soon have a Gujarat model of growth in China.” And Mukesh Ambani said RIL is first a Gujarati co, then an Indi...

First day of the sixth edition of 'Vibrant Gujarat' saw investment commitments of Rs 28,000 crore from corporates such as Essar, ABG Shipya...

Now pharma is a main buzz word. So anything which has pharma behind its name or any of its activity that is pharma besides its name the sto...

Investors can look at accumulating it, but with a clear eye on whether there is improvement in performance in the June quarter.

In an interview with ET Now, Shyam S Bhartia, Chairman and MD, Jubilant Life Sciences, talks about the company's order book and future stra...

If demerging of Jubilant Lifesciences' agri and polymers business had raised investors' hopes in the company, its December quarter performa...

Jubilant Energy will raise $85 million by selling a 21.8% stake to institutional investors and will start trading on the London Stock Excha...

The company has decided to spin off its consumer products and application polymer division, which has annual sales of around Rs 200 crore.